Hypertension
New data from Brazil, Russia and Taiwan illuminate research in hypertension
Published in Hospital Business Week, August 12th, 2007
Study 1: Fresh data on hypertension are presented in the report "Cyclic guanosine monophosphate phosphodiesterase-5 inhibitor promotes an endothelium NO-dependent-like vasodilation in patients with refractory hypertension." According to recent research published in the journal Nitric Oxide, "The nitric oxide/cyclic-guanosine 3',5'-monophosphate signaling cascade plays an essential role in cardiovascular homeostasis but its involvement in the pathophysiology of refractory hypertension is unclear. The acute vasodilatory effect of a single oral dose of a phosphodiesterase-5 inhibitor...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Business Week
More Articles from Hospital Business Week
- Affymetrix Inc.
Children's Hospital of Philadelphia Selects Affymetrix SNP Array 6.0 for Series of Whole-genome Association Studies across 7,000 Samples - Aging
First-Annual Aging Revolution Summit to Address a New Model for Aging Services - Air Methods Corporation
Air Methods Products Division Awarded HH-60 MedEvac Upgrade Contract - Allscripts
Walla Walla Clinic Selects Allscripts Electronic Health Record - Amcom Software
Two-Thirds of America's Best Hospitals Rely on Amcom Software for Mission-Critical Communications - American Federation of Government Employees
AFGE to Testify Before Senate Committee on Veterans Affairs - More from this issue of Hospital Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
